NYSE:CLColgate-Palmolive Stock Price, Forecast & News

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CL stock has increased by 11.8% and is now trading at $77.05.
View which stocks have been most impacted by COVID-19.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Colgate-Palmolive.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) released its earnings results on Friday, July, 31st. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.05. The business earned $3.90 billion during the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The firm's quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.72 earnings per share.
View Colgate-Palmolive's earnings history.

Colgate-Palmolive announced a quarterly dividend on Thursday, June 11th. Investors of record on Monday, July 20th will be paid a dividend of $0.44 per share on Friday, August 14th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Friday, July 17th.
View Colgate-Palmolive's dividend history.

12 brokers have issued 12 month price targets for Colgate-Palmolive's stock. Their forecasts range from $58.00 to $88.00. On average, they anticipate Colgate-Palmolive's stock price to reach $75.82 in the next year. This suggests that the stock has a possible downside of 1.6%.
View analysts' price targets for Colgate-Palmolive.

Media coverage about CL stock has trended neutral this week, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colgate-Palmolive earned a news impact score of 0.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about Colgate-Palmolive.

Some companies that are related to Colgate-Palmolive include Procter & Gamble (PG), Kimberly Clark (KMB), Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), Coca-Cola (KO), Mcdonald's (MCD), Walmart (WMT) and Intel (INTC).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.00%), BlackRock Inc. (6.57%), Bank of New York Mellon Corp (2.09%), First Eagle Investment Management LLC (1.46%), California Public Employees Retirement System (0.56%) and Swiss National Bank (0.43%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., FIL Ltd, FMR LLC, Toronto Dominion Bank, AJO LP, Bank of New York Mellon Corp, and Alyeska Investment Group L.P.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran.
View insider buying and selling activity for Colgate-Palmolive.

CL stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, M&G Investment Management Ltd., GUARDCAP ASSET MANAGEMENT Ltd, Conning Inc., Sarasin & Partners LLP, Glenmede Trust Co. NA, CIBC Asset Management Inc, and Prio Wealth Limited Partnership.
View insider buying and selling activity for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CL stock can currently be purchased for approximately $77.05.

Colgate-Palmolive has a market capitalization of $66.06 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]